secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2024-01-04T23:59:59+00:00
Accession:  0001493152-24-001103
Event type: regulatory
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

INBS regains Nasdaq compliance on stockholders' equity, but faces ongoing monitoring
--------------------------------------------------------------------------------

- Nasdaq confirmed compliance with $2.5M min. equity requirement after INBS reported $4.24M equity as of Oct 31, 2023.
- Equity increase primarily from public offering that closed Oct 4, 2023.
- Nasdaq warned that failure to maintain compliance in next 10-Q (Dec 31, 2023) could lead to delisting.
- Company still does not meet alternative listing standards (market value of $35M or net income of $500K).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315224001103/0001493152-24-001103-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315224001103/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-001103

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer